IL1B and Cognitive impairment: Diabetic rats administered TDF exhibited cognitive deficits; and increases in blood glucose, malondialdehyde, and interleukin-1 beta (IL-1β) levels, which correlate with decreases in glutathione level, and superoxide dismutase (SOD) and catalase (CAT) activities.